Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER1 | P34995 | 7/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 2/20 | 0.42 |
| ▸ | HTR2B | P41595 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | RBP4 | P02753 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28942782 | 0.80 | LMNA (0.48) | GAAMEN1ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL20612921 | 0.78 | FFAR4 (0.44) | ALDH1A1 | |
| SCHEMBL19899240 | 0.78 | GAA (0.43) | GAAMEN1ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL14098668 | 0.78 | PTGER1 (0.57) | PTGER1 | |
| SCHEMBL16731569 | 0.76 | KMT2A (0.49) | GAAMEN1ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL2958946 | 0.76 | PTGER1 (0.76) | PTGER1 | |
| SCHEMBL31063330 | 0.76 | PTGER1 (0.43) | PTGER1GAAHTR2CHTR2BMEN1 | |
| SCHEMBL4091719 | 0.75 | PTGER1 (0.56) | PTGER1 | |
| SCHEMBL838576 | 0.75 | KMT2A (0.48) | GAAMEN1ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL137173 | 0.75 | ABL1 (0.43) | GAAALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4665339-A1 | INHIBITING ALPHA V BETA 8 INTEGRIN | Morphic Therapeutic, Inc. (US) | 2025-12-24 | — | — | EP | disclosed |
| WO-2024173570-A1 | INHIBITING αvβ8 INTEGRIN | MORPHIC THERAPEUTIC, INC. (US) | 2024-08-22 | — | — | WO | disclosed |